½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Cardiac Arrhythmia Monitoring Devices Market, By Product Type, By Application, By End User,, By Geography
»óǰÄÚµå
:
1747290
¸®¼Ä¡»ç
:
Coherent Market Insights
¹ßÇàÀÏ
:
2025³â 05¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2025³â¿¡ 94¾ï 4,000¸¸ ´Þ·¯, 2032³â¿¡´Â 159¾ï 7,000¸¸ ´Þ·¯¿¡ À̸£°í, 2025-2032³â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 7.8%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.
º¸°í¼ ¹üÀ§
º¸°í¼ »ó¼¼
±âÁØ ¿¬µµ
2024
2025³â ½ÃÀå ±Ô¸ð
94¾ï 4,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ
2020-2024³â
¿¹Ãø ±â°£
2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR
7.80%
2032³â °¡Ä¡ ¿¹Ãø
159¾ï 7,000¸¸ ´Þ·¯
ºÎÁ¤¸ÆÀ̶ó°íµµ ¾Ë·ÁÁø ½ÉÀå ºÎÁ¤¸ÆÀº Àü ¼¼°èÀûÀ¸·Î ¼ö¹é¸¸ ¸íÀÌ ¾Î°í ÀÖ´Â ÈçÇÑ ½ÉÇ÷°ü°è ÁúȯÀÔ´Ï´Ù. ºÎÁ¤¸ÆÀº ½ÉÀåÀÇ ºñÁ¤»óÀûÀÎ Àü±âÀû ½ÅÈ£°¡ Ư¡À̸ç, È¿°úÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ°í °ü¸®ÇÏÁö ¾ÊÀ¸¸é ´Ù¾çÇÑ ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÃÖ±Ù ºÎÁ¤¸ÆÀÇ Áø´Ü°ú ÃßÀûÀ» µ½°í Àû½Ã¿¡ °³ÀÔÇÏ¿© ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÒ ¼ö ÀÖ´Â ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¿ªÇÐ:
¼¼°è ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ÀåÄ¡ ½ÃÀåÀº ÇâÈÄ ¸î ³â µ¿¾È Å« ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, ½ÉÀå °Ç°¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÀÇ·á ±â¼úÀÇ ¹ßÀü µî ¿©·¯ °¡Áö ¿äÀÎÀÌ ÀÌ·¯ÇÑ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÉÀå ºÎÁ¤¸Æ¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸ Áõ°¡µµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
½ÃÀå ±â¾÷µéÀº ±ÔÁ¦ ´ç±¹ÀÇ Á¦Ç° ½ÂÀÎÀ» ¹Þ±â À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ¿¹Ãø ±â°£ µ¿¾È ¼¼°è ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ÀåÄ¡ ½ÃÀåÀÇ ¼ºÀåÀ» Áõ°¡½Ãų °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹¸¦ µé¾î, ¸ÂÃãÇü ½ÉÀå Áø´Ü ¹× ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç Á¦°ø¾÷üÀÎ Global Instrumentation LLC´Â 2021³â 1¿ù 10ÀÏ ¹Ì±¹ ½ÄǰÀǾ౹(FDA)ÀÇ ½ÂÀÎÀ» ¹ÞÀº M5 ¿þ¾î·¯ºí ECG ·¹ÄÚ´õÀÇ CE ¸¶Å© ÀÎÁõÀ» ȹµæÇß½À´Ï´Ù. ·¹ÄÚ´õ¿¡ ´ëÇÑ CE ¸¶Å© ÀÎÁõÀ» ȹµæÇß½À´Ï´Ù.
±×·¯³ª ½ÃÀåÀº ¸î °¡Áö ¾ïÁ¦¿äÀο¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ±× Áß Çϳª´Â ÀÌ·¯ÇÑ ±â±âÀÇ ³ôÀº ºñ¿ëÀ¸·Î ÀÎÇØ Àú¼Òµæ Áö¿ªÀÇ È¯Àڵ鿡°Ô Á¢±ÙÇÏ±â ¾î·Æ´Ù´Â Á¡ÀÔ´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ ±â±âÀÇ µ¥ÀÌÅ͸¦ È¿°úÀûÀ¸·Î »ç¿ëÇϰí ÇØ¼®ÇÒ ¼ö ÀÖ´Â ¼÷·ÃµÈ ÀÇ·á Àü¹®°¡°¡ ºÎÁ·ÇÏ´Ù´Â Á¡µµ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
ÀÌ·¯ÇÑ µµÀü¿¡µµ ºÒ±¸Çϰí, ½ÃÀå ±â¾÷ÀÌ È°¿ëÇÒ ¼ö ÀÖ´Â ±âȸ´Â ÃæºÐÇÕ´Ï´Ù. ÀΰøÁö´É ¹× ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÇ ÅëÇÕ°ú °°Àº ±â¼ú ¹ßÀüÀº º¸´Ù Á¤È®Çϰí È¿À²ÀûÀÎ ¸ð´ÏÅ͸µ ÀåºñÀÇ °³¹ßÀ» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå¿¡ »õ·Î¿î ±æÀ» ¿¾îÁÖ°í ÀÖ½À´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
º» º¸°í¼´Â 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© 2025-2032³â±îÁöÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Æ÷ÇÔÇÑ ¼¼°è ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ÀåÄ¡ ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿´½À´Ï´Ù.
ÀÌ º¸°í¼´Â ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °íÂûÀ» Á¦°øÇÕ´Ï´Ù.
ÁÖ¿ä Á¶»ç ´ë»ó ±â¾÷Àº Medtronic, Abbott Laboratories, Boston Scientific, Biotronic, Koninklijke Philips, Nippon Photonics, Fukuda Electronics, Hylom Holdings, Mindray Medical, Schiller AG, Spacelabs Healthcare, GE Healthcare, Cardiac Science Corporation, Lifewatch AG, Beijing Choice Electronic Tech Co. Spacelabs Healthcare,GE Healthcare,Cardiac Science Corporation,Lifewatch AG,Beijing Choice Electronic Tech Co,Vivaquant,Preventice Solutions, iRhythm Technologies,Applied Cardiovascular Technologies,Applied Cardiovascular Solutions iRhythm Technologies, Applied Cardiac Systems, BioTelemetry µîÀÔ´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷ÀÇ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, Á¦Ç° ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ÀåÄ¡ ¼¼°è ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ÀåÄ¡ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç
Á¦2Àå ½ÃÀå Àü¸Á
º¸°í¼ ¼³¸í
ÁÖ¿ä ¿ä¾à
Coherent Opportunity Map(COM)
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®
½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀÎ
¼ºÀå ¾ïÁ¦¿äÀÎ
±âȸ
¿µÇ⠺м®
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
±ÔÁ¦ ½Ã³ª¸®¿À
Á¦Ç° ¹ß¸Å/½ÂÀÎ
PEST ºÐ¼®
PORTER ºÐ¼®
ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À
Á¦4Àå ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå, Á¦Ç° À¯Çüº°, 2020³â-2032³â
¾ÈÁ¤½Ã ½ÉÀüµµ Àåºñ
ECG ½ºÆ®·¹½º Å×½ºÆ® Àåºñ
¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ¸ð´ÏÅÍ
À̽ÄÇü ½ÉÀå ¸ð´ÏÅÍ
ȦÅÍ ¸ð´ÏÅÍ
À̺¥Æ® ¸ð´ÏÅÍ
±âŸ(¿þ¾î·¯ºí ½ÉÀüµµ ¸ð´ÏÅÍ, ½º¸¶Æ® ½ÉÀüµµ ¸ð´ÏÅÍ)
Á¦5Àå ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå, ¿ëµµº°, 2020³â-2032³â
¼¸Æ
ºó¸Æ
½É¹æ¼¼µ¿
±â¿Ü ¼öÃà
Àüµµ Àå¾Ö
±âŸ(½É½Ç¼¼µ¿, ÆäÀÌ½Ì ¸ð´ÏÅ͸µ)
Á¦6Àå ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020³â-2032³â
º´¿ø
Áø´Ü¼¾ÅÍ
¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
ȨÄɾî ȯ°æ
±âŸ(¿¬±¸±â°ü, Àü¹® Ŭ¸®´Ð)
Á¦7Àå ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå, Áö¿ªº°, 2020³â-2032³â
ºÏ¹Ì
¶óƾ¾Æ¸Þ¸®Ä«
ºê¶óÁú
¾Æ¸£ÇîÆ¼³ª
¸ß½ÃÄÚ
±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
À¯·´
µ¶ÀÏ
¿µ±¹
½ºÆäÀÎ
ÇÁ¶û½º
ÀÌÅ»¸®¾Æ
·¯½Ã¾Æ
±âŸ À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç
Áß±¹
Àεµ
ÀϺ»
È£ÁÖ
Çѱ¹
ASEAN
±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
秵¾ÆÇÁ¸®Ä«
³²¾ÆÇÁ¸®Ä«
ºÏ¾ÆÇÁ¸®Ä«
Áß¾Ó¾ÆÇÁ¸®Ä«
Á¦8Àå °æÀï ±¸µµ
Medtronic
Abbott Laboratories
Boston Scientific
Biotronik
Koninklijke Philips
Nihon Kohden
Fukuda Denshi
Hill-Rom Holdings
Mindray Medical
Schiller AG
Spacelabs Healthcare
GE Healthcare
Cardiac Science Corporation
Lifewatch AG
Beijing Choice Electronic Tech Co
Vivaquant
Preventice Solutions
iRhythm Technologies
Applied Cardiac Systems
BioTelemetry
Á¦9Àå ¼½¼Ç
LSH
¿µ¹® ¸ñÂ÷
Cardiac Arrhythmia Monitoring Devices Market is estimated to be valued at USD 9.44 Bn in 2025 and is expected to reach USD 15.97 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 9.44 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
7.80%
2032 Value Projection:
USD 15.97 Bn
Cardiac arrhythmia, also known as an irregular heartbeat, is a common cardiovascular condition that affects millions of people worldwide. It is characterized by abnormal electrical signals in the heart, which can lead to various complications if not monitored and managed effectively. In recent years, there has been a growing demand for cardiac arrhythmia monitoring devices that can help diagnose and track the condition, thereby enabling timely interventions and improving patient outcomes.
Market Dynamics:
The global cardiac arrhythmia monitoring devices market is set to experience significant growth in the coming years. Several factors are driving this growth, including the rising prevalence of cardiovascular diseases, increasing awareness about heart health, and advancements in medical technology. Moreover, the growing geriatric population, which is more susceptible to cardiac arrhythmias, is also contributing to the market's expansion.
Market players are engaged in receiving approval from the regulatory authorities for their products, and this is expected to increase the growth of the global cardiac arrhythmia monitoring devices market over the forecast period. For instance, on January 10, 2022, Global Instrumentation LLC, a provider of customized cardiac diagnostic and monitoring solutions, received the CE Mark certification for the M5 wearable ECG recorder that had earlier been approved by the U.S. Food and Drug Administration (U.S. FDA) authority in January 2021.
However, the market does face some restraints. One such restraint is the high cost associated with these devices, making them less accessible to patients in low-income regions. Additionally, the lack of skilled healthcare professionals who can effectively use and interpret the data from these devices poses a challenge to the market's growth.
Despite these challenges, there are ample opportunities for market players to capitalize on. Technological advancements, like the integration of artificial intelligence and machine learning algorithms, are enabling the development of more accurate and efficient monitoring devices. Furthermore, the increasing adoption of telemedicine and remote patient monitoring solutions is opening up new avenues for the market.
Key features of the study:
This report provides in-depth analysis of the global cardiac arrhythmia monitoring devices market, including market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period of 2025-2032, with 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
Key companies covered in this study include Medtronic, Abbott Laboratories, Boston Scientific, Biotronik, Koninklijke Philips, Nihon Kohden, Fukuda Denshi, Hill-Rom Holdings, Mindray Medical, Schiller AG, Spacelabs Healthcare, GE Healthcare, Cardiac Science Corporation, Lifewatch AG, Beijing Choice Electronic Tech Co, Vivaquant, Preventice Solutions, iRhythm Technologies, Applied Cardiac Systems, and BioTelemetry
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, product upgrades, market expansion, and marketing tactics
The global cardiac arrhythmia monitoring devices market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac arrhythmia monitoring devices market
Global Cardiac Arrhythmia Monitoring Devices Market Segmentation:
By Product Type
Resting ECG Devices
ECG Stress Test Devices
Mobile Cardiac Telemetry Monitors
Implantable Cardiac Monitors
Holter Monitors
Event Monitors
Others (Wearable ECG Monitors, Smart ECG Monitors)
By Application
Bradycardia
Tachycardia
Atrial Fibrillation
Premature Contraction
Conduction Disorders
Others (Ventricular Fibrillation, Pacing Monitoring)
By End User
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers
Homecare Settings
Others (Research Institutes, Specialty Clinics)
By Region
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Top companies in Global Cardiac Arrhythmia Monitoring Devices Market:
Medtronic
Abbott Laboratories
Boston Scientific
Biotronik
Koninklijke Philips
Nihon Kohden
Fukuda Denshi
Hill-Rom Holdings
Mindray Medical
Schiller AG
Spacelabs Healthcare
GE Healthcare
Cardiac Science Corporation
Lifewatch AG
Beijing Choice Electronic Tech Co
Vivaquant
Preventice Solutions
iRhythm Technologies
Applied Cardiac Systems
BioTelemetry
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Cardiac Arrhythmia Monitoring Devices, By Product Type
Market Cardiac Arrhythmia Monitoring Devices, By Application
Market Cardiac Arrhythmia Monitoring Devices, By End User
Market Cardiac Arrhythmia Monitoring Devices, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
The rising prevalence of cardiovascular diseases
The lack of skilled healthcare professionals
Technological advancements, like the integration of artificial intelligence and machine learning algorithms
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
4. Cardiac Arrhythmia Monitoring Devices Market , By Product Type, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Resting ECG Devices
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
ECG Stress Test Devices
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Mobile Cardiac Telemetry Monitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Implantable Cardiac Monitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Holter Monitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Event Monitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others (Wearable ECG Monitors, Smart ECG Monitors)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
5. Cardiac Arrhythmia Monitoring Devices Market , By Application, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2023and 2032 (%)
Y-o-Y Growth Analysis, 2021- 2032
Segment Trends
Bradycardia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Tachycardia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Atrial Fibrillation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Premature Contraction
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Conduction Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others (Ventricular Fibrillation, Pacing Monitoring)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Cardiac Arrhythmia Monitoring Devices Market , By End User, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2023and 2032 (%)
Y-o-Y Growth Analysis, 2021- 2032
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Diagnostic Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Homecare Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others (Research Institutes, Specialty Clinics)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Cardiac Arrhythmia Monitoring Devices Market , By Region, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, By Country, 2023and 2032 (%)
Y-o-Y Growth Analysis, For Country 2021-2032
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Regions, 2020-2032,(US$ Bn)
South Africa
North Africa
Central Africa
8. Competitive Landscape
Medtronic
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Abbott Laboratories
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Boston Scientific
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Biotronik
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Koninklijke Philips
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Nihon Kohden
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Fukuda Denshi
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Hill-Rom Holdings
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Mindray Medical
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Schiller AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Spacelabs Healthcare
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
GE Healthcare
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Cardiac Science Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Lifewatch AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Beijing Choice Electronic Tech Co
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Vivaquant
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Preventice Solutions
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
iRhythm Technologies
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Applied Cardiac Systems
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
BioTelemetry
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
9. Section
Research Methodology
About us
°ü·ÃÀÚ·á